What Is a Normal SHBG Level in Perimenopause?

What Is a Normal SHBG Level in Perimenopause?

For most perimenopausal women, an SHBG level between 40–120 nmol/L is considered within the broadly normal reference range — but that range is wide for a reason. What matters clinically is whether your SHBG is pushing free estrogen or free testosterone out of reach. High SHBG (above 120–130 nmol/L) can leave you feeling exhausted and flat despite "normal" total hormone levels; low SHBG (below 30 nmol/L) is often tied to insulin resistance and may increase estrogen-driven tissue exposure. The sweet spot is individual — and context-dependent.

---

What SHBG Actually Does — and Why Perimenopause Changes Everything

SHBG is a glycoprotein produced primarily in the liver. Its job is to bind to sex hormones — estradiol, testosterone, and dihydrotestosterone (DHT) — and carry them through the bloodstream in an inactive form. Only the "free" fraction of a hormone that isn't bound to SHBG (or albumin) can enter cells and produce biological effects.

This means SHBG acts like a volume dial for your hormones. A high SHBG level turns down the biological activity of estrogen and testosterone even if your total levels look fine on paper. A low SHBG level turns the dial up — more free hormone, more cellular activity.

During perimenopause — the 4–10 year transition before the final menstrual period — ovarian estradiol output becomes erratic. As estradiol drops on average, SHBG loses one of its main stimulators, which is why many women see SHBG fall across the menopausal transition. However, because estradiol fluctuates wildly in early perimenopause, SHBG can actually be elevated in some months and suppressed in others, making a single snapshot measurement easy to misread.

A large prospective analysis from the Study of Women's Health Across the Nation (SWAN) confirmed that SHBG declines progressively across the menopausal transition, and that lower SHBG independently predicts metabolic risk factors including insulin resistance and dyslipidemia — findings relevant to why normal cholesterol levels in perimenopause are harder to maintain in this window (Sutton-Tyrrell et al., Circulation 2005; PMID: 15867183).

---

The Reference Range — and Why "Normal" Isn't the Same as Optimal

Standard laboratory reference ranges for SHBG in premenopausal adult women typically run from about 17 to 120 nmol/L, with some labs extending to 130 nmol/L. For postmenopausal women, labs often cite 17–120 nmol/L as well, but population data consistently shows SHBG rising after the final menstrual period as estrogen's suppressive effect on liver SHBG production is removed.

Oral estrogen therapy dramatically raises SHBG — sometimes by 2–4× — because it passes through the liver before reaching the bloodstream, stimulating hepatic SHBG synthesis. Transdermal estradiol, which bypasses first-pass liver metabolism, raises SHBG far less. This distinction matters clinically: a woman on oral estrogen may have "normal" total testosterone but barely any free testosterone because her SHBG has been pushed so high (Kuhl 2005, Gynecological Endocrinology; PMID: 16390757).

---

What Drives SHBG Up or Down in Perimenopause?

Because SHBG is made in the liver, anything that alters liver function or hepatic signaling pathways will shift your level. Understanding the drivers helps you interpret your result — and gives your clinician targets to address.

Factors that raise SHBG:

• Estrogen (especially oral/synthetic forms)
• Thyroid hormone (elevated T3/T4 stimulates SHBG production)
• High-fiber, low-fat dietary patterns
• Caloric restriction
• Certain medications (phenytoin, some antifungals)

Factors that lower SHBG:

• Insulin resistance and hyperinsulinemia — the most clinically significant driver (Plymate et al., Journal of Clinical Endocrinology & Metabolism 1988; PMID: 3372679)
• Androgens (testosterone, DHEA, anabolic steroids)
• Hypothyroidism — low thyroid hormone reduces SHBG synthesis, which is one reason checking thyroid status alongside SHBG is recommended; for context on what a normal thyroid level looks like postpartum illustrates how tightly thyroid and SHBG interact
• Obesity and visceral adiposity
• High-dose glucocorticoids
• Alcohol (in excess)
• Progestins (synthetic, especially 19-nortestosterone derivatives)

The insulin–SHBG relationship is perhaps the most actionable. Elevated fasting insulin suppresses hepatic SHBG production through an insulin-response element on the SHBG gene promoter. This means women with insulin resistance often have paradoxically low SHBG despite having adequate or even elevated total estrogen — a combination that increases free estrogen exposure at tissues while simultaneously reducing the protective effects of sex hormone binding. Understanding what causes fasting insulin to be out of range is therefore a practical complement to interpreting any SHBG result.

---

SHBG, Free Testosterone, and Perimenopausal Symptoms

One of the most underappreciated relationships in perimenopause is between SHBG and free testosterone. Many women in their 40s experience loss of libido, fatigue, and muscle weakness — symptoms often attributed to low estrogen — but in a meaningful subset, the real problem is that SHBG has risen high enough to strip away functional testosterone even when total testosterone is in the normal range.

A 2002 analysis in the Journal of Clinical Endocrinology & Metabolism found that free testosterone index (total testosterone ÷ SHBG × 100) was a better predictor of sexual function complaints than total testosterone alone in perimenopausal women (Guay et al., JCEM 2002; PMID: 12364440). This is why some practitioners calculate the Free Androgen Index (FAI) rather than relying on total testosterone alone — a number that is worth tracking alongside normal testosterone levels in perimenopause.

Conversely, when SHBG is low — often in women with higher BMI or insulin resistance — free testosterone can be elevated even if total testosterone is mid-range. This pattern is common in polycystic ovary syndrome (PCOS) and can persist into perimenopause, contributing to androgen-driven symptoms such as acne, hair thinning at the crown, and mood volatility.

---

How Stress Affects SHBG: The Cortisol Connection

Cortisol is a major contributor to SHBG fluctuations that many women don't expect. Chronic psychological or physiological stress elevates cortisol, which in turn promotes insulin resistance over time and suppresses gonadal hormone output — both of which pull SHBG lower. Meanwhile, elevated cortisol is directly catabolic to the hormones SHBG would otherwise bind, creating a cascade that compounds the hormonal disorganization of perimenopause.

Practically, stress management is not a soft add-on to SHBG optimization — it's a biochemical necessity. Interventions that measurably lower cortisol include:

1. Consistent sleep of 7–9 hours (cortisol is highly circadian)
2. Resistance training 2–3× per week (which also improves insulin sensitivity)
3. Mindfulness-based stress reduction (MBSR) — an 8-week RCT published in Psychoneuroendocrinology found significant reductions in morning cortisol (Matousek et al., 2010; PMID: 20022165)
4. Adaptogenic herbs validated in human trials (discussed below)
5. Reducing reliance on high-glycemic foods, which spike insulin and thereby suppress SHBG

Women dealing with sustained perimenopausal symptoms — fatigue, brain fog, weight redistribution, mood changes — often report that stress is a major amplifier of their symptom burden. This is consistent with the cortisol–insulin–SHBG axis: when stress is poorly managed, the hormonal environment becomes more volatile, and symptoms worsen non-linearly.

---

SHBG and the Longer Arc of Perimenopause

Perimenopause is not a short window. For many women it spans 7–12 years, and symptoms — hot flashes, sleep disruption, cognitive changes, mood instability, joint pain, vaginal changes — can evolve significantly over that time. SHBG is not a static number; it shifts as the transition progresses.

Women in early perimenopause with high SHBG may feel most of their hormone-related symptoms are from "not enough free estrogen" even when serum estradiol appears adequate. Later in the transition, as estradiol falls more consistently and SHBG begins to rise (post-menopause), the same woman may actually feel better in some respects — symptom phenotype genuinely changes.

Tracking SHBG annually alongside estradiol, FSH, total testosterone, and free testosterone index gives a fuller picture than any single biomarker. For women also monitoring LH as part of their transition surveillance, understanding what a normal LH level looks like in perimenopause provides important context for the full hormonal picture.

Digestive symptoms — constipation being among the most common — also peak during perimenopause and are frequently underconnected to hormonal changes. Estrogen and progesterone both modulate gut motility, and as their levels fluctuate, bowel regularity often suffers. Low SHBG in the context of high free androgens can also influence gut transit time indirectly through androgen receptor activity on intestinal smooth muscle. These connections are still being characterized in the literature, but they explain why some women notice GI symptoms improving when hormonal balance improves.

---

What This Means for Your Formula

SHBG optimization is primarily a metabolic and hepatic problem — so the most relevant nutritional targets are the ones that support insulin sensitivity, liver function, and the adrenal axis.

Ashwagandha (KSM-66®, 600 mg): The most rigorously studied adaptogen for HPA-axis regulation. An 8-week double-blind RCT in 64 adults found KSM-66 reduced serum cortisol by 27.9% versus placebo (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Because cortisol chronically suppresses SHBG through insulin-mediated pathways, cortisol reduction is a meaningful upstream target. Ones includes KSM-66 at the full 600 mg clinical dose.

Omega-3 fatty acids (EPA + DHA): Higher omega-3 intake is associated with improved insulin sensitivity and reduced hepatic triglyceride accumulation — both of which support healthier SHBG levels. A meta-analysis in Nutrition & Metabolism (Gao et al., 2017) found that omega-3 supplementation significantly reduced fasting insulin in metabolic syndrome populations. Ones formulas include pharmaceutical-grade EPA/DHA dosed to clinically relevant levels based on an individual's lipid and inflammation markers.

Magnesium Glycinate (within Ones' Magnesium Complex): Magnesium deficiency is strongly associated with insulin resistance — a systematic review of 25 studies found lower serum magnesium was consistently linked to insulin resistance (Barbagallo & Dominguez, World Journal of Diabetes 2015; PMID: 26322160). Correcting magnesium status helps restore insulin signaling, which in turn supports SHBG production at the liver. When a user's labs indicate low magnesium or signs of insulin resistance, Ones may include its Magnesium Complex to address both pathways simultaneously.

None of these ingredients directly raises SHBG like a switch — they address the metabolic and stress-driven conditions that suppress it. That's what makes personalized formulation more useful than a generic supplement stack: you need to know which driver is dominant for your biology before choosing the intervention.

---

Key Takeaways

• Normal SHBG in perimenopause is roughly 35–120 nmol/L, but the functional range depends on your free hormone levels, symptoms, and metabolic context — a single number without clinical interpretation is limited.
• High SHBG can starve cells of free estrogen and testosterone even when total hormone levels look adequate; low SHBG is often a downstream signal of insulin resistance.
• Oral estrogen therapy significantly raises SHBG; transdermal estradiol does not — this distinction is clinically relevant if you're on or considering HRT.
• Insulin resistance is the most modifiable driver of low SHBG in perimenopausal women — addressing it through diet, movement, and targeted supplementation can produce meaningful SHBG shifts.
• Chronic stress suppresses SHBG indirectly through cortisol-driven insulin resistance; stress management is a biochemical, not just a psychological, intervention.
• Track SHBG alongside free testosterone, estradiol, FSH, and fasting insulin for a complete hormonal picture — each marker provides context the others cannot.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your supplement or hormone therapy regimen.